Remdesivir inches nearer to EU’s underlying authorisation as coronavirus treatment Kumar Jeetendra | May 18, 2020 The leader of the European Union’s drugs office Guido Rasi said on Monday an underlying authorisation for U.S. pharmaceutical organization Gilead’s remdesivir as a COVID-19 treatment could be conceded in coming days. The European Medicines Agency (EMA) has just suggested the caring utilization of remdesivir, which permits a medication to be directed to patients even …
